The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
Open accessAbstract
The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1. Mutation of ATM occurs in the human autosomal recessive disorder ataxia-telangiectasia, which is characterized by hypersensitivity to ionizing radiation and a failure of cells to arrest the cell cycle after the induction of DNA double-strand breaks. It has thus been proposed that ATM inhibition would cause cellular radio- and chemosensitization. Through screening a small molecule compound library developed for the phosphatidylinositol 3'-kinase-like kinase family, we identified an ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933), that inhibits ATM with an IC(50) of 13 nmol/L and a Ki of 2.2 nmol/L. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3'-kinase-like kinases. Cellular inhibition of ATM by KU-55933 was demonstrated by the ablation of ionizing radiation-dependent phosphorylation of a range of ATM targets, including p53, gammaH2AX, NBS1, and SMC1. KU-55933 did not show inhibition of UV light DNA damage induced cellular phosphorylation events. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also caused a loss of ionizing radiation-induced cell cycle arrest. By contrast, KU-55933 did not potentiate the cytotoxic effects of ionizing radiation on ataxia-telangiectasia cells, nor did it affect their cell cycle profile after DNA damage. We conclude that KU-55933 is a novel, specific, and potent inhibitor of the ATM kinase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translocation of USP10 could be blocked by the ATM inhibitor Ku55933”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Hickson et al., 2004
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Walker, E. H., Pacold, M. E., Perišić, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,211
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,050
Research works printed but not linked: 1
- Ormerod MG Analysis of DNA-general methods Ormerod MG eds. . Flow cytometry 200083-97. Oxford University Press Oxford, UK
Cited by
Sorted by citations
Items 201–300 of 1,000
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Gustafsson, N., Färnegårdh, K., Bonagas, N., Ninou, A. H., Groth, P., Wiita, E., Jönsson, M., Hallberg, K., Lehto, J., Pennisi, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06287-x · Cited by 128
Deans, A. J., Khanna, K. K., McNees, C. J., Mercurio, C., Heierhorst, J., & McArthur, G. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3945 · Cited by 125
ATM Acts Downstream of ATR in the DNA Damage Response Signaling of Bystander Cells
Burdak‐Rothkamm, S., Rothkamm, K., & Prise, K. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0545 · Cited by 124
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Shi, Y., Felley‐Bosco, E., Marti, T. M., Orlowski, K., Pruschy, M. N., & Stahel, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-571 · Cited by 124
Poly(ADP-ribose) polymerase inhibitors in cancer treatment: A clinical perspective
Sandhu, S. K., Yap, T. A., & Bono, J. S. D. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.021 · Cited by 123
Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei
Dillon, M. T., Barker, H. E., Pedersen, M., Hafsi, H., Bhide, S. A., Newbold, K. L., Nutting, C. M., McLaughlin, M., & Harrington, K. J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0239 · Cited by 129
Nuclear constriction segregates mobile nuclear proteins away from chromatin
Irianto, J., Pfeifer, C. R., Bennett, R. R., Xia, Y., Ivanovska, I. L., Liu, A. J., Greenberg, R. A., & Discher, D. E. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-06-0428 · Cited by 128
ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib
Wang, C., Jette, N., Moussienko, D., Bebb, D. G., & Lees‐Miller, S. P. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.007 · Cited by 125
Zhao, J., Zhang, L., Lu, A., Han, Y., Colangelo, D., Bukata, C., Scibetta, A., Yousefzadeh, M. J., Li, X., Gurkar, A. U., et al. (2020) · Aging · doi:10.18632/aging.102863 · Cited by 122
AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner
Sun, Y., Connors, K. E., & Yang, D.-Q. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9575-6 · Cited by 122
ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells
Ronco, C., Martin, A. R., Demange, L., & Benhida, R. (2016) · MedChemComm · doi:10.1039/c6md00439c · Cited by 131
Jekimovs, C., Bolderson, E., Suraweera, A., Adams, M. N., O'Byrne, K. J., & Richard, D. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00086 · Cited by 123
Targeting DNA repair mechanisms in cancer
Furgason, J. M., & Bahassi, E. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.009 · Cited by 122
Hendriks, G., Atallah, M., Morolli, B., Calléja, F. M. G. R., Ras-Verloop, N., Huijskens, I., Raamsman, M., van de Water, B., & Vrieling, H. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr281 · Cited by 121
Li, Y., & Yang, D.-Q. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1189 · Cited by 124
Emerging cancer therapeutic opportunities target DNA-repair systems
Ding, J., Miao, Z., Meng, L., & Geng, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.007 · Cited by 119
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F‐1 after DNA damage
Inoue, Y., Kitagawa, M., & Taya, Y. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601652 · Cited by 119
Ha, K., Lee, G. E., Palii, S. S., Brown, K. D., Takeda, Y., Liu, K., Bhalla, K. N., & Robertson, K. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq451 · Cited by 127
KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis
Tian, C., Xing, G., Xie, P., Lu, K., Nie, J., Wang, J., Li, L., Gao, M., Zhang, L., & He, F. (2009) · Nature Cell Biology · doi:10.1038/ncb1864 · Cited by 120
MRE11–RAD50–NBS1 and ATM function as co-mediators of TRF1 in telomere length control
Wu, Y., Xiao, S., & Zhu, X. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1286 · Cited by 119
Kanai, R., Rabkin, S. D., Yip, S. S. F., Sgubin, D., Zaupa, C., Hirose, Y., Louis, D. N., Wakimoto, H., & Martuza, R. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr509 · Cited by 119
RETRACTION: XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage
Lévy, N., Martz, A., Bresson, A., Spenlehauer, C., de MURCIA, G., & Murcia, J. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj409 · Cited by 119
RetractedUse of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy
Sak, A., & Stuschke, M. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.004 · Cited by 113
Targeting homologous recombination repair defects in cancer
Evers, B., Helleday, T., & Jonkers, J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.001 · Cited by 115
FBH1 Catalyzes Regression of Stalled Replication Forks
Fugger, K., Mistrík, M., Neelsen, K. J., Yao, Q., Zellweger, R., Kousholt, A. N., Haahr, P., Chu, W. K., Bártek, J., Lopes, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.028 · Cited by 125
Self-citationAdams, B. R., Golding, S. E., Rao, R. R., & Valerie, K. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010001 · Cited by 115
Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice
Yamamoto, K., Wang, Y., Jiang, W., Liu, X., Dubois, R. L., Lin, C., Ludwig, T., Bakkenist, C. J., & Zha, S. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201204098 · Cited by 118
DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Kelley, M. R., & Fishel, M. L. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784220294 · Cited by 114
Activation of the ATM-Snail pathway promotes breast cancer metastasis
Sun, M., Guo, X., Qian, X., Wang, H., Yang, C., Brinkman, K. L., Gonzalez, M. S., Jope, R. S., Zhou, B. P., Engler, D. A., et al. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs048 · Cited by 111
Identification and characterization of FUS/TLS as a new target of ATM
Gardiner, M., Toth, R., Vandermoere, F., Morrice, N. A., & Rouse, J. (2008) · Biochemical Journal · doi:10.1042/bj20081135 · Cited by 111
Targeting the Checkpoint to Kill Cancer Cells
Benada, J., & Macůrek, L. (2015) · Biomolecules · doi:10.3390/biom5031912 · Cited by 115
Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair
Sone, K., Piao, L., Nakakido, M., Ueda, K., Jenuwein, T., Nakamura, Y., & Hamamoto, R. (2014) · Nature Communications · doi:10.1038/ncomms6691 · Cited by 109
Amiard, S., Charbonnel, C., Allain, E., Depeiges, A., White, C. I., & Gallego, M. E. (2010) · The Plant Cell · doi:10.1105/tpc.110.078527 · Cited by 115
Solier, S., Sordet, O., Kohn, K. W., & Pommier, Y. G. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00581-08 · Cited by 112
Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks
Williamson, L. M., & Lees‐Miller, S. P. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq255 · Cited by 112
Directing the use of DDR kinase inhibitors in cancer treatment
Brandsma, I., Fleuren, E. D. G., Williamson, C. T., & Lord, C. J. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1389895 · Cited by 108
YU, Y., Mahaney, B. L., YANO, K., Ye, R., FANG, S., DOUGLAS, P., Chen, D., & Lees‐Miller, S. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.06.015 · Cited by 109
Kass, E. M., Helgadottir, H. R., Chen, C.-C., Barbera, M. A., Wang, R., Westermark, U., Ludwig, T., Moynahan, M. E., & Jasin, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216824110 · Cited by 110
Loss of ATM kinase activity leads to embryonic lethality in mice
Daniel, J. A., Pellegrini, M., Lee, B.-S., Guo, Z., Filsuf, D., Belkina, N. V., You, Z., Paull, T. T., Sleckman, B. P., Feigenbaum, L., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201204035 · Cited by 111
Parvovirus Minute Virus of Mice Induces a DNA Damage Response That Facilitates Viral Replication
Adeyemi, R. O., Landry, S., Davis-Gardner, M. E., Weitzman, M. D., & Pintel, D. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001141 · Cited by 105
Yoon, J., Ahn, S., Lee, B., Jung, S.-H., & Oh, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.029 · Cited by 107
ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells
Lee, S. S., Bohrson, C. L., Pike, A. M., Wheelan, S. J., & Greider, C. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.035 · Cited by 103
Kim, Y.-E., Gwak, S.-H., Hong, B.-J., Oh, J.-M., Choi, H.-S., Kim, M. S., Oh, D., Lartey, F. M., Rafat, M., Schüler, E., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.11.012 · Cited by 112
Gallmeier, E., Hermann, P. C., Mueller, M.-T., Machado, J. G., Ziesch, A., Toni, E. N. D., Palagyi, A., Eisen, C., Ellwart, J. W., Rivera, J., et al. (2011) · Stem Cells · doi:10.1002/stem.595 · Cited by 106
Munoz, I. M., Jowsey, P. A., Toth, R. L., & Rouse, J. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm493 · Cited by 113
Gannon, H. S., Woda, B. A., & Jones, S. N. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.011 · Cited by 105
Golding, S. E., Rosenberg, E., Adams, B. R., Wignarajah, S., Beckta, J. M., O’Connor, M. J., & Valerie, K. C. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19576 · Cited by 109
Bauerschmidt, C., Arrichiello, C., Burdak‐Rothkamm, S., Woodcock, M., Hill, M. A., Stevens, D. L., & Rothkamm, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp976 · Cited by 105
Choudhury, A., Cuddihy, A. R., & Bristow, R. G. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.007 · Cited by 104
Zhao, X., Madden-Fuentes, R. J., Lou, B. X., Pipas, J. M., Gerhardt, J., Rigell, C. J., & Fanning, E. (2008) · Journal of Virology · doi:10.1128/jvi.02677-07 · Cited by 104
Gunn, A., Bennardo, N., Cheng, A., & Stark, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309252 · Cited by 106
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
Pich, D., Mrozek-Górska, P., Bouvet, M., Sugimoto, A., Akidil, E., Grundhoff, A. T., Hamperl, S., Ling, P. D., & Hammerschmidt, W. (2019) · mBio · doi:10.1128/mbio.01723-19 · Cited by 99
Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability
Blickwedehl, J., Agarwal, M., Seong, C., PANDITA, R. K., Melendy, T., Sung, P., Pandita, T. K., & Bangia, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803145105 · Cited by 103
Tardif, K. D., Rogers, A., Cassiano, J., Roth, B. L., Cimbora, D. M., McKinnon, R. S., Peterson, A., Douce, T. B., Robinson, R., Dorweiler, I. J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0453 · Cited by 105
Kletsas, D. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1132 · Cited by 106
APE2 is required for ATR-Chk1 checkpoint activation in response to oxidative stress
Willis, J., Patel, Y., Lentz, B. L., & Yan, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301445110 · Cited by 100
Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
Sultana, R., Abdel-Fatah, T. M. A., Abbotts, R., Hawkes, C., Albarakati, N., Seedhouse, C., Ball, G., Chan, S. Y. T., Rakha, E. A., Ellis, I. O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2929 · Cited by 100
Teng, P.-N., Bateman, N. W., Darcy, K. M., Hamilton, C. A., Maxwell, G. L., Bakkenist, C. J., & Conrads, T. P. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.035 · Cited by 102
DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism
Fan, S., Meng, Q., Xu, J., Jiao, Y., Zhao, L., Zhang, X., Sarkar, F. H., Brown, M. L., Dritschilo, A., & Rosen, E. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308206110 · Cited by 99
Role of cell cycle regulators in lung carcinogenesis
Eymin, B., & Gazzéri, S. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.10977 · Cited by 98
DNA repair inhibition: a selective tumour targeting strategy
Madhusudan, S., & Hickson, I. D. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.09.004 · Cited by 99
Self-citationPeltonen, K., Colis, L. C., Liu, H., Jäämaa, S., Moore, H. M., Enbäck, J., Laakkonen, P., Vaahtokari, A., Jones, R. J., af Hällström, T. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012996 · Cited by 107
Luthra, P., Aguirre, S., Yen, B. C., Pietzsch, C. A., Sánchez-Aparicio, M. T., Tigabu, B., Morlock, L., García‐Sastre, A., Leung, D. W., Williams, N. S., et al. (2017) · mBio · doi:10.1128/mbio.00368-17 · Cited by 101
DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer
Velic, D., Couturier, A. M., Ferreira, M., Rodrigue, A., Poirier, G. G., Fleury, F., & Masson, J. (2015) · Biomolecules · doi:10.3390/biom5043204 · Cited by 106
Mahajan, K. N., Coppola, D., Rawal, B., Chen, Y. A., Lawrence, H. R., Engelman, R. W., Lawrence, N. J., & Mahajan, N. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357384 · Cited by 98
Targeting the Double-Strand DNA Break Repair Pathway as a Therapeutic Strategy
Lord, C. J., Garrett, M. D., & Ashworth, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1269 · Cited by 99
Targeting DNA repair as a promising approach in cancer therapy
Damia, G. L. M., & D’Incalci, M. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.05.003 · Cited by 99
PTEN Functions by Recruitment to Cytoplasmic Vesicles
Naguib, A., Bencze, G., Cho, H., Wu, Z., Tocilj, A., Elkayam, E., Faehnle, C. R., Jaber, N. L., Pratt, C. P., Chen, M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.011 · Cited by 99
Alekseev, S., Ayadi, M., Brino, L., Egly, J., Larsen, A. K., & Coin, F. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.014 · Cited by 97
Rashid, A., Liu, C., Sanli, T., Tsiani, E., Singh, G., Bristow, R. G., Dayes, I. S., Lukka, H. R., Wright, J. R., & Tsakiridis, T. K. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-144 · Cited by 100
Spreading of mammalian DNA‐damage response factors studied by ChIP‐chip at damaged telomeres
Meier, A., Fiegler, H., Muñoz, P., Ellis, P., Rigler, D., Langford, C., Blasco, M. A., Carter, N., & Jackson, S. P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601719 · Cited by 100
Self-citationGenotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells
Phan, R. T., Saito, M., Kitagawa, Y., Means, A. R., & Dalla‐Favera, R. (2007) · Nature Immunology · doi:10.1038/ni1508 · Cited by 97
Zhan, H., Suzuki, T., Aizawa, K., Miyagawa, K., & Nagai, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125138 · Cited by 101
Norman, J. M., Mashiba, M., McNamara, L. A., Onafuwa-Nuga, A., Chiari, E. F., Shen, W., & Collins, K. L. (2011) · Nature Immunology · doi:10.1038/ni.2087 · Cited by 95
Unravelling the genomic targets of small molecules using high-throughput sequencing
Rodriguez, R., & Miller, K. M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3796 · Cited by 100
Baritaud, M., Cabon, L., Delavallée, L., Galán‐Malo, P., Me, G., Brunelle-Navas, M.-N., & Susín, S. A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.120 · Cited by 98
Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo
Lin, C., Yu, Y., Zhao, H.-G., Yang, A., Yan, H., & Cui, Y. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.10.023 · Cited by 98
The cell cycle checkpoint inhibitors in the treatment of leukemias
di Rorà, A. G. L., Iacobucci, I., & Martinelli, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0443-x · Cited by 95
Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage
Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00562-06 · Cited by 93
ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres
Thanasoula, M., Escandell, J. M., Suwaki, N., & Tarsounas, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.191 · Cited by 99
Osterwald, S., Deeg, K. I., Chung, I., Parisotto, D., Wörz, S., Rohr, K., Erfle, H., & Rippe, K. (2015) · Journal of Cell Science · doi:10.1242/jcs.148296 · Cited by 92
Xu, L. H., Huang, M., Fang, S. G., & Liu, D. X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.242206 · Cited by 92
Fernet, M., Mégnin-Chanet, F., Hall, J. A., & Favaudon, V. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.10.006 · Cited by 94
Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy
Farkas, T., Daugaard, M., & Jäättelä, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269134 · Cited by 91
Viral and Cellular Genomes Activate Distinct DNA Damage Responses
Shah, G., & O’Shea, C. C. (2015) · Cell · doi:10.1016/j.cell.2015.07.058 · Cited by 105
DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies
Wang, Q. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.57 · Cited by 92
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway
Wallace, N. A., Khanal, S., Robinson, K. L., Wendel, S. O., Messer, J. J., & Galloway, D. A. (2017) · Journal of Virology · doi:10.1128/jvi.01084-17 · Cited by 94
Cancer Nanomedicine: A New Era of Successful Targeted Therapy
El-Readi, M. Z., & Althubiti, M. (2019) · Journal of Nanomaterials · doi:10.1155/2019/4927312 · Cited by 92
Therapeutic Targeting of DNA Damage Response in Cancer
Choi, W., & Lee, E. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031701 · Cited by 97
Perspective on the Pipeline of Drugs Being Developed with Modulation of DNA Damage as a Target
Plummer, R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0984 · Cited by 90
Targeting the DNA damage response for cancer therapy
Powell, S. N., & Bindra, R. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.011 · Cited by 86
RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation
Badie, S., Liao, C., Thanasoula, M., Barber, P. R., Hill, M. A., & Tarsounas, M. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200811079 · Cited by 90
Carlessi, L., Buscemi, G., Larson, G., Hong, Z., Wu, J. Z., & Delia, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0567 · Cited by 89
Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection
Cai, M., Dunn, C. E., Chen, W., Kochupurakkal, B. S., Nguyen, H. Q., Moreau, L. A., Shapiro, G. I., Parmar, K., Kozono, D., & D’Andrea, A. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.052 · Cited by 91
Tong, X., Zhou, L., Wang, Y., Xia, C., Wang, Y., Liang, M., Hou, F. F., & Cheng, Y. (2010) · Organic Letters · doi:10.1021/ol100451p · Cited by 88
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
Olofsson, B. A., Kelly, C. M., Kim, J., Hornsby, S. M., & Azizkhan‐Clifford, J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0374 · Cited by 89
NFκB/p53 crosstalk—a promising new therapeutic target
Schneider, G., & Krämer, O. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.003 · Cited by 87
Katsube, T., Mori, M., Tsuji, H., Shiomi, T., Wang, B., Liu, Q., Nenoi, M., & Onoda, M. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu021 · Cited by 94
Freschauf, G. K., Karimi‐Busheri, F., Ulaczyk‐Lesanko, A., Mereniuk, T. R., Ahrens, A., Koshy, J. M., Rasouli‐Nia, A., Pasarj, P., Holmes, C. F. B., Rininsland, F. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1805 · Cited by 87
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage
Salzano, M., Sanz-García, M., Monsalve, D. M., Moura, D. S., & Lazo, P. A. (2015) · Epigenetics · doi:10.1080/15592294.2015.1028708 · Cited by 87
Metadata
- Authors
- Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M.
- Affiliations
- 1KuDOS Pharmaceuticals Ltd., Cambridge Science Park, Milton Road, Cambridge;
- Newcastle University (GB)
- University of Cambridge (GB)
- ORCID
- Venue
- Cancer Research
- Published
- 2004-12-15
- Volume
- 64
- Issue
- 24
- Pages
- 9152-9159
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2101988823
- Cited by
- 1,220
- References
- 58
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 38 · 2023: 49 · 2022: 31 · 2021: 32 · 2020: 53 · 2019: 55 · 2018: 48 · 2017: 66 · 2016: 71 · 2015: 76 · 2014: 70 · 2013: 62 · 2012: 92
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ATM kinase, KU55933, kinase inhibitors, ataxia telangiectasia, radiosensitivity, DNA double-strand breaks, cell cycle arrest, p53 phosphorylation, NBS1, radiosensitization, chemosensitization, etoposide, doxorubicin, camptothecin, γH2AX, SMC1A
- MeSH terms
- Cell Cycle, Chromones, DNA-Binding Proteins, HeLa Cells, Humans, Kinetics, Morpholines, Phosphorylation, Pyrones, Radiation-Sensitizing Agents, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Inhibitory Concentration 50, Combinatorial Chemistry Techniques, Tumor Suppressor Proteins, Cell Line, Tumor, Protein Kinase Inhibitors, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review